Table 1.
Tumour type | Reference | n | R2 | p (1-tailed) | Median time interval (days) | Median time interval/DTe | Average SGR (%/d) | Relative uncertainty of SGR (%) | DTe (days) | Relative uncertainty of volume estimation (%) |
---|---|---|---|---|---|---|---|---|---|---|
Meningioma |
Nakamura et al.
[29] |
41 |
0.2424 |
0.0005 |
1230 |
0.71 |
0.04 |
105 |
1733 |
37 |
Hepatocellular carcinoma |
Nakajima et al.
[27] |
34 |
0.038 |
NS (0.13) |
128 |
2.4 |
1.30 |
73 |
53 |
86 |
|
Saito et al.
[28] |
21 |
0.0623 |
NS (0.14) |
146 |
1.05 |
0.50 |
47 |
139 |
24 |
|
Taouli et al.
[26] |
16 |
0.0014 |
NS (0.89) |
NA |
NA |
0.90 |
115 |
77 |
NA |
Pancreatic carcinoma |
Furukawa et al.
[25] |
9 |
0.0248 |
NS (0.34) |
295 |
2.13 |
0.50 |
58 |
139 |
60 |
Primary Lung Cancer |
Wang et al.
[24] |
12 |
0.1619 |
NS (0.19) |
365 |
4.21 |
0.80 |
36 |
87 |
74 |
|
El Sharouni et al.
[23] |
18 |
0.2713 |
0.026 |
48 |
1.94 |
2.80 |
73 |
25 |
69 |
REGROWTH |
n: number of tumours.
R: correlation coefficient. Median time interval is calculated from measurement time intervals between the first and the second tumour volume measurements. NA: not available. NS: not statistically significant (p-values in parentheses). DTe: equivalent doubling time. DTe and uncertainty calculations were done according to previously published methods [7]. Regrowth in the last row means that the calculation has been done for regrowth of tumours after induction chemotherapy.